Proliferative retinopathies: Angiogenesis that blinds

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 1, 2010, Pages 5-12

  Sapieha, Przemyslaw ^a   Hamel, David ^b   Shao, Zhuo ^b   Rivera, Jose Carlos ^b   Zaniolo, Karine ^b   Joyal, Jean Sébastien ^b   Chemtob, Sylvain ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Angiogenesis; Blindness; Diabetes; Prematurity; Retinopathy

Indexed keywords

OMEGA 3 FATTY ACID; OXYGEN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; VASCULOTROPIN ANTIBODY;

AGE; ANGIOGENESIS; BLINDNESS; CELL THERAPY; CLINICAL TRIAL; CRYOTHERAPY; DIABETIC RETINOPATHY; DISEASE MODEL; HEALTH CARE SYSTEM; HUMAN; HYPOXIA; INDUSTRIALIZATION; INFLAMMATION; LASER COAGULATION; METABOLITE; NONHUMAN; OXYGEN TOXICITY; OXYGEN TRANSPORT; PATHOGENESIS; PEDIATRICS; PRODUCTIVITY; RETINA BLOOD FLOW; RETINA MACULA AGE RELATED DEGENERATION; RETINA VEIN OCCLUSION; RETINOPATHY; RETROLENTAL FIBROPLASIA; RISK FACTOR; SCAR FORMATION; SHORT SURVEY; SIGNAL TRANSDUCTION; VITRECTOMY;

ANIMALS; BLINDNESS; BLOOD VESSELS; EYE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; RETINAL DISEASES;

EID: 70549086876     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.10.006     Document Type: Short Survey

References (75)

1. Abran D., Varma D.R., and Chemtob S. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol 268 (1995) H628-H632
2. Abran D., Hardy P., Varma D.R., and Chemtob S. Mechanisms of the biphasic effects of peroxides on the retinal vasculature of newborn and adult pigs. Exp Eye Res 61 (1995) 285-292
3. Abu el Asrar A.M., Maimone D., Morse P.H., Gregory S., and Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114 (1992) 731-736
4. Adamis A.P., and Berman A.J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30 (2008) 65-84
5. Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1 (1995) 1024-1028
6. Ashton N., Ward B., and Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 38 (1954) 397-432
7. Auge N., Pieraggi M.T., Thiers J.C., Negre-Salvayre A., and Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J 309 Part 3 (1995) 1015-1020
8. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
9. Bell E.F., and Klein J.M. Comments on oxygen toxicity and retinopathy (ROP) in the premature infant. Iowa neonatology handbook: pulmonary (1994), University of Iowa, Children's hospital, Department of Pediatrics
10. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25 (2006) 397-424
11. Bruick R.K. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 97 (2000) 9082-9087
12. Bruick R.K. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 17 (2003) 2614-2623
13. Canataroglu H., Varinli I., Ozcan A.A., Canataroglu A., Doran F., and Varinli S. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocul Immunol Inflamm 13 (2005) 375-381
14. Carmo A., Cunha-Vaz J.G., Carvalho A.P., and Lopes M.C. l-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity. Vision Res 39 (1999) 3817-3823
15. Chen J., and Smith L.E. Retinopathy of prematurity. Angiogenesis 10 (2007) 133-140
16. Chen J., Connor K.M., Aderman C.M., and Smith L.E. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118 (2008) 526-533
17. Clark A.N., Youkey R., Liu X., Jia L., Blatt R., Day Y.J., et al. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ Res 101 (2007) 1130-1138
18. Connor K.M., SanGiovanni J.P., Lofqvist C., Aderman C.M., Chen J., Higuchi A., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13 (2007) 868-873
19. Cronstein B.N. Adenosine receptors and wound healing. ScientificWorldJournal 4 (2004) 1-8
20. D'Amore P.A., and Sweet E. Effects of hyperoxia on microvascular cells in vitro. In Vitro Cell Dev Biol 23 (1987) 123-128
21. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
22. Dorrell M., and Friedlander M. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog Retin Eye Res 25 (2006) 277-295
23. Dorrell M.I., Aguilar E., and Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci 43 (2002) 3500-3510
24. Dorrell M.I., Aguilar E., Jacobson R., Trauger S.A., Friedlander J., Siuzdak G., et al. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia 58 1 (2010) 43-54
25. Dumont I., Peri K.G., Hardy P., Hou X., Martinez-Bermudez A.K., Molotchnikoff S., et al. PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period. Am J Physiol 275 (1998) R1812-R1821
26. Dumont I., Hou X., Hardy P., Peri K.G., Beauchamp M., Najarian T., et al. Developmental regulation of endothelial nitric oxide synthase in cerebral vessels of newborn pig by prostaglandin E(2). J Pharmacol Exp Ther 291 (1999) 627-633
27. Ehinger B., and Falck B. Concomitant adrenergic and parasympathetic fibres in the rat iris. Acta Physiol Scand 67 (1966) 201-207
28. Engerman R.L. Pathogenesis of diabetic retinopathy. Diabetes 38 (1989) 1203-1206
29. Engerman R.L., and Kern T.S. Retinopathy in animal models of diabetes. Diabetes Metab Rev 11 (1995) 109-120
30. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:741-56.
31. Fletcher E.L., Downie L.E., Ly A., Ward M.M., Batcha A.H., Puthussery T., et al. A review of the role of glial cells in understanding retinal disease. Clin Exp Optom 91 (2008) 67-77
32. Flynn J.T., Bancalari E., Snyder E.S., Goldberg R.N., Feuer W., Cassady J., et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 326 (1992) 1050-1054
33. Friedman D.S., O'Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
34. Funatsu H., Yamashita H., Shimizu E., Kojima R., and Hori S. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina 21 (2001) 469-477
35. Gilbert C., Rahi J., Eckstein M., O'Sullivan J., and Foster A. Retinopathy of prematurity in middle-income countries. Lancet 350 (1997) 12-14
36. Guyton A.C. The relationship of cardiac output and arterial pressure control. Circulation 64 (1981) 1079-1088
37. Halks-Miller M., Henderson M., and Eng L.F. Alpha tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain. J Neuropathol Exp Neurol 45 (1986) 471-484
38. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A.L., Liu J.L., et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98 (2001) 5804-5808
39. Hoste A.M., Boels P.J., Andries L.J., Brutsaert D.L., and De Laey J.J. Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro. Invest Ophthalmol Vis Sci 31 (1990) 1231-1237
40. Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., Bursell S.E., and Adamis A.P. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158 (2001) 147-152
41. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Dohmen S., et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16 (2002) 438-440
42. Jung Y.J., Isaacs J.S., Lee S., Trepel J., and Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003) 2115-2117
43. Kempen J.H., O'Colmain B.J., Leske M.C., Haffner S.M., Klein R., Moss S.E., et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122 (2004) 552-563
44. Kociok N., Radetzky S., Krohne T.U., Gavranic C., and Joussen A.M. Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Invest Ophthalmol Vis Sci 47 (2006) 5057-5065
45. Kondo T., Kinouchi H., Kawase M., and Yoshimoto T. Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neurosci Lett 215 (1996) 103-106
46. Kowluru R.A., and Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88 (2004) 1343-1347
47. Laties A.M. Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol 77 (1967) 405-409
48. Limb G.A., Chignell A.H., Green W., LeRoy F., and Dumonde D.C. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 80 (1996) 168-173
49. Lutty G.A., Cao J., and McLeod D.S. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 151 (1997) 707-714
50. Michaelson I. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. Trans Ophthalmol Soc UK 68 (1948) 137-180
51. Moncada S., Higgs A., and Furchgott R. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 49 (1997) 137-142
52. Navarro J.F., and Mora-Fernandez C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17 (2006) 441-450
53. Nielsen J.C., Naash M.I., and Anderson R.E. The regional distribution of vitamins E and C in mature and premature human retinas. Invest Ophthalmol Vis Sci 29 (1988) 22-26
54. Niesman M.R., Johnson K.A., and Penn J.S. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res 22 (1997) 597-605
55. Otani A., Kinder K., Ewalt K., Otero F.J., Schimmel P., and Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8 (2002) 1004-1010
56. Parker L.H., Schmidt M., Jin S.W., Gray A.M., Beis D., Pham T., et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428 (2004) 754-758
57. Paul S.A., Simons J.W., and Mabjeesh N.J. HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 200 (2004) 20-30
58. Penn J.S., Tolman B.L., and Lowery L.A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci 34 (1993) 576-585
59. Penn J.S., Tolman B.L., and Bullard L.E. Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radic Biol Med 22 (1997) 977-984
60. Priestley J. Experiments and observations on different kinds of air vol. 2 (1775), J Johnson, St. Paul's Churchyard, London p. 101-2
61. Raju T.N., Langenberg P., Bhutani V., and Quinn G.E. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr 131 (1997) 844-850
62. Roth A.M. Retinal vascular development in premature infants. Am J Ophthalmol 84 (1977) 636-640
63. SanGiovanni J.P., and Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24 (2005) 87-138
64. SanGiovanni J.P., Chew E.Y., Clemons T.E., Davis M.D., Ferris III F.L., Gensler G.R., et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 125 (2007) 671-679
65. Sapieha P., Sirinyan M., Hamel D., Zaniolo K., Joyal J.S., Cho J.H., et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 14 (2008) 1067-1076
66. Sennlaub F., Valamanesh F., Vazquez-Tello A., El-Asrar A.M., Checchin D., Brault S., et al. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108 (2003) 198-204
67. Serhan C.N., Chiang N., and Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8 (2008) 349-361
68. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35 (1994) 101-111
69. Spranger J., Meyer-Schwickerath R., Klein M., Schatz H., and Pfeiffer A. TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy. Med Klin (Munich) 90 (1995) 134-137
70. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
71. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol 1995;113:36-51.
72. Weinberger B., Watorek K., Strauss R., Witz G., Hiatt M., and Hegyi T. Association of lipid peroxidation with hepatocellular injury in preterm infants. Crit Care 6 (2002) 521-525
73. Wenger R.H., Stiehl D.P., and Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005 (2005) re12
74. Wheatcroft S.B., Williams I.L., Shah A.M., and Kearney M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20 (2003) 255-268
75. Yuuki T., Kanda T., Kimura Y., Kotajima N., Tamura J., Kobayashi I., et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 15 (2001) 257-259